Back to top

Repligen price target raised to $175 from $165 at JPMorgan

JPMorgan raised the firm’s price target on Repligen (RGEN) to $175 from $165 and keeps an Overweight rating on the shares. Published first on TheFl...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Repligen Corporation (RGEN)